Literature DB >> 1893383

Growth and metastasis of fresh human melanoma tissue in mice with severe combined immunodeficiency.

L L Hill1, R Korngold, C Jaworsky, G Murphy, P McCue, D Berd.   

Abstract

Cryopreserved cell suspensions of freshly excised melanoma metastases from nine patients were injected s.c. into C.B-17 severe combined immunodeficiency (SCID) mice. All 9 tumors grew as s.c. masses and six of nine were successfully transplanted into other SCID mice. Transplant inocula as low as 5 x 10(5) cells resulted in 100% tumor incidence. Moreover, seven of nine tumors metastasized, five from the original s.c. implants and two from transplanted s.c. tumors. Metastases were detected mainly in the lungs but also were found in abdominal viscera (liver, spleen, and pancreas) and thoracic lymph nodes. Flow cytometric analysis showed that expression of a panel of melanoma antigens, melanoma-associated proteoglycan, ganglioside GD3, and ganglioside GD2, was maintained with SCID passage. The original tumor inocula contained a variable percentage of tumor-associated lymphocytes (1-76%). Flow cytometry analysis indicated that these were mainly CD3+ T-cells. However, there was no correlation between the percentage of tumor-associated lymphocytes and the time required for development of a palpable tumor after s.c. injection or the ability to metastasize. These results demonstrate the growth and spontaneous metastasis of fresh human melanoma in SCID mice and suggest that this model could be important for therapeutic and basic biological studies.

Entities:  

Mesh:

Year:  1991        PMID: 1893383

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Engraftment of precursor lesions of human cutaneous neoplasms onto C.B-17 SCID mice: a useful in vivo experimental model of carcinogenesis in human skin.

Authors:  Y Takizawa; T Saida; Y Tokuda; S Dohi; S Ikegawa; Y Ueyama
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

3.  Comparative studies between nude and scid mice on the growth and metastatic behavior of xenografted human tumors.

Authors:  X Xie; N Brünner; G Jensen; J Albrectsen; B Gotthardsen; J Rygaard
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

4.  Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin.

Authors:  Kavindra Nath; David S Nelson; Daniel F Heitjan; Dennis B Leeper; Rong Zhou; Jerry D Glickson
Journal:  NMR Biomed       Date:  2014-12-12       Impact factor: 4.044

5.  Mature helper T cell requirement for immunoglobulin production by neonatal native B cells injected intraperitoneally into severe combined immunodeficient (SCID) mice.

Authors:  M Hasui; T Miyawaki; T Ichihara; Y Niida; K Iwai; A Yachie; H Seki; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

6.  (31) P and (1) H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan.

Authors:  Kavindra Nath; David S Nelson; Andrew M Ho; Seung-Cheol Lee; Moses M Darpolor; Stephen Pickup; Rong Zhou; Daniel F Heitjan; Dennis B Leeper; Jerry D Glickson
Journal:  NMR Biomed       Date:  2012-06-29       Impact factor: 4.044

7.  Growth and invasion of human melanomas in human skin grafted to immunodeficient mice.

Authors:  I Juhasz; S M Albelda; D E Elder; G F Murphy; K Adachi; D Herlyn; I T Valyi-Nagy; M Herlyn
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine.

Authors:  D Shrayer; H Bogaars; V J Hearing; A Maizel; H Wanebo
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

9.  Bonded Cumomer Analysis of Human Melanoma Metabolism Monitored by 13C NMR Spectroscopy of Perfused Tumor Cells.

Authors:  Alexander A Shestov; Anthony Mancuso; Seung-Cheol Lee; Lili Guo; David S Nelson; Jeffrey C Roman; Pierre-Gilles Henry; Dennis B Leeper; Ian A Blair; Jerry D Glickson
Journal:  J Biol Chem       Date:  2015-12-24       Impact factor: 5.157

10.  The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters.

Authors:  Bethany Nancolas; Lili Guo; Rong Zhou; Kavindra Nath; David S Nelson; Dennis B Leeper; Ian A Blair; Jerry D Glickson; Andrew P Halestrap
Journal:  Biochem J       Date:  2016-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.